In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity-Reference-Cited by-同舟云学术

In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity

Published:2023-06-05 Issue:7 Volume:64 Page:10
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Ma Sen¹,Huis In't Veld Ruben V.²³,Houy Alexander⁴,Stern Marc-Henri⁴,Rich Cadmus⁵,Ossendorp Ferry A.³,Jager Martine J.¹

Affiliation:

1. Department of Ophthalmology, Leiden University Medical Center (LUMC), Leiden, The Netherlands

2. Department of Radiology, Leiden University Medical Center (LUMC), Leiden, The Netherlands

3. Department of Immunology, Leiden University Medical Center (LUMC), Leiden, The Netherlands

4. Inserm U380, DNA Repair and Uveal Melanonoma (D.R.U.M.), Equipe labelliseé par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, Paris, France

5. Aura Biosciences, Inc., Cambridge, Massachusetts, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference45 articles.

1. Incidence of uveal melanoma in Europe;Virgili;Ophthalmology,2007

2. Incidence of uveal melanoma in the United States: 1973–1997;Singh;Ophthalmology,2003

3. Five decades of enucleations for uveal melanoma in one center: more tumors with high risk factors, no improvement in survival over time;Roelofsen;Ocul Oncol Pathol,2021

4. Uveal melanoma;Jager;Nat Rev Dis Primers,2020

5. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18;Diener-West;Arch Ophthalmol,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions;Pharmacological Research;2024-09

2. Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma;British Journal of Ophthalmology;2024-07-04

3. Recent Advances in Molecular and Genetic Research on Uveal Melanoma;Cells;2024-06-12

4. Uveal melanoma: Current evidence on prognosis, treatment and potential developments;Asia-Pacific Journal of Ophthalmology;2024-03

5. Targeted therapy in ophthalmic oncology: The current status;Asia-Pacific Journal of Ophthalmology;2024-03